Amendment to Separation Agreement between Akebia Therapeutics, Inc. and Nicole R. Hadas (February 2024)
Contract Categories:
Human Resources
›
Separation Agreements
Summary
This amendment updates the Separation Agreement between Akebia Therapeutics, Inc. and Nicole R. Hadas. It changes the date of Ms. Hadas's employment separation to June 14, 2024, unless her employment ends earlier for cause or good reason as defined in a prior agreement. Any further changes to the separation date require written agreement from both parties. All other terms of the original Separation Agreement remain unchanged.
EX-10.66 9 akbaex1066hadas_nicolexame.htm EX-10.66 Document
Exhibit 10.66
February 8, 2024
BY EMAIL
Nicole R. Hadas
[Address]
Dear Nikki:
Upon your execution of this Amendment, the following amendments will be made to your Separation Agreement with Akebia Therapeutics, Inc. (“Akebia”) dated May 5, 2022 (as previously amended, the “Separation Agreement”). Paragraph 1(ii) of the Separation Agreement shall be replaced in its entirety with the following:
(ii) Separation Date. Unless your employment is terminated by the Company for Cause or by you for Good Reason (as those terms are defined in your Executive Severance Agreement dated March 3, 2014, the “ESA”), you will remain employed until June 14, 2024 (as may be amended from time to time, the "Separation Date"). The Separation Date may be modified only upon mutual written agreement between you and the Company.
All other terms and conditions of the Separation Agreement shall remain in full force and effect.
Very truly yours,
AKEBIA THERAPEUTICS, INC. Accepted and Agreed to Under Seal:
/s/ John P. Butler______________________ /s/ Nicole R. Hadas__________________
President and Chief Executive Officer Nicole R. Hadas
Dated: February 8, 2024
